Despite the US sanctions, Iranian pharmaceutical experts in Semnan, east to Tehran, have managed to indigenize the production of gelatin capsules and coated tablets.

Iran PressIran news: Using modern state-of-the-art equipment, Sana Med Company has launched its product line of gelatin layer and full-automatic medicine injection process.

For ease of use, proper dosage and absorption, some generic medicines that do not taste good, or should not come into contact with air are produced as 'soft gel'.

Despite the fact that two years have passed from the opening of the production unit, it produces 90,000 to 150,000 tablets per hour and 10 billion tablets and capsules annually confirmed by world certifications for the treatment of neurological, respiratory, gastrointestinal, renal, cardiovascular, anti-inflammatory, anti-allergic and analgesic patients.

By March 2020, thirty generic medicines will be added to the production line.

With an investment of 300 billion Rials and 17 million Euros, Sana Med Pharmaceutical Company is among the top ten Iranian pharmaceutical companies which are reducing the dependence of Iran on imported generic medicines.

205/211/214

Read More:

Iran's new medicine to be unveiled on Sunday

Share of Iran's knowledge-based medical equipment companies reaches %72

Iranian made complex medical equipment to be unveiled soon: Sattari